BNF FOR CHILDREN MARCH 2023
This update contains 1 significant change, 2 dose changes, 2 new monographs, and 1 new preparation.
•Genital system infections, antibacterial therapy: updated guidance for the management of uncomplicated genital chlamydia and gonorrhoea.
•Azithromycin [update to dosing for uncomplicated genital chlamydia in children from 12 years old, and update to include dosing in children from 12 years old for uncomplicated gonorrhoea].
•Ceftriaxone [update to dosing for pelvic inflammatory disease in children from 12 years old, and update to dosing for uncomplicated gonorrhoea and congenital gonococcal conjunctivitis].
• Tezspire® [tezepelumab].
• Xenpozyme® [olipudase alfa].
• DuoResp Spiromax® [budesonide with formoterol].
For further details on changes in the BNFC click on https://www.medicinescomplete.com/#/content/bnfc/PHP107699?hspl=changes